nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—P2RY12—forebrain—attention deficit hyperactivity disorder	0.113	0.246	CbGeAlD
Ticagrelor—P2RY12—cardiovascular system—attention deficit hyperactivity disorder	0.0958	0.208	CbGeAlD
Ticagrelor—P2RY12—nervous system—attention deficit hyperactivity disorder	0.0615	0.134	CbGeAlD
Ticagrelor—P2RY12—central nervous system—attention deficit hyperactivity disorder	0.0592	0.129	CbGeAlD
Ticagrelor—P2RY12—brain—attention deficit hyperactivity disorder	0.047	0.102	CbGeAlD
Ticagrelor—P2RY12—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0248	0.046	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.0175	0.0324	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0167	0.0309	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0155	0.0287	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0152	0.0281	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.015	0.0279	CbGpPWpGaD
Ticagrelor—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0139	0.0303	CbGeAlD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0133	0.0246	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.013	0.0241	CbGpPWpGaD
Ticagrelor—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.0118	0.0256	CbGeAlD
Ticagrelor—P2RY12—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.0113	0.021	CbGpPWpGaD
Ticagrelor—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.0107	0.0232	CbGeAlD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0105	0.0195	CbGpPWpGaD
Ticagrelor—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.0103	0.0224	CbGeAlD
Ticagrelor—P2RY12—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0101	0.0187	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00989	0.0183	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00989	0.0183	CbGpPWpGaD
Ticagrelor—ABCB1—midbrain—attention deficit hyperactivity disorder	0.0092	0.02	CbGeAlD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.0092	0.017	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00918	0.017	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00902	0.0167	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.009	0.0167	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00891	0.0165	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00875	0.0162	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00865	0.016	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00853	0.0158	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0085	0.0158	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00827	0.0153	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00812	0.0151	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00805	0.0149	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00802	0.0149	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00787	0.0146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00772	0.0143	CbGpPWpGaD
Ticagrelor—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00756	0.0164	CbGeAlD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00748	0.0138	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00731	0.0135	CbGpPWpGaD
Ticagrelor—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00729	0.0135	CbGpPWpGaD
Ticagrelor—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00728	0.0158	CbGeAlD
Ticagrelor—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00712	0.0155	CbGeAlD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00708	0.0131	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00696	0.0129	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00687	0.0127	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00685	0.0127	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0064	0.0119	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00599	0.0111	CbGpPWpGaD
Ticagrelor—ABCB1—brain—attention deficit hyperactivity disorder	0.00578	0.0126	CbGeAlD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0057	0.0106	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00559	0.0104	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00557	0.0103	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00539	0.00999	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0053	0.00982	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00524	0.0097	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00524	0.0097	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00518	0.00959	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00507	0.0094	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00488	0.00904	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00474	0.00878	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00456	0.00845	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00449	0.00831	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00387	0.00717	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00356	0.0066	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00352	0.00652	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00342	0.00633	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00338	0.00627	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00315	0.00583	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00307	0.00569	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00306	0.00567	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00305	0.00565	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.003	0.00555	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.003	0.00555	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00296	0.00548	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00294	0.00545	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00286	0.00529	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00277	0.00513	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00276	0.00511	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00272	0.00504	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00269	0.00498	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0025	0.00464	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0024	0.00445	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00229	0.00424	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00224	0.00415	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00208	0.00385	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00193	0.00358	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00182	0.00336	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.0018	0.00333	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00175	0.00325	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00171	0.00318	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00169	0.00313	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00163	0.00303	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00162	0.003	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00161	0.00298	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00159	0.00294	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00148	0.00274	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0012	0.00222	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00119	0.00221	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00118	0.00219	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00104	0.00192	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000836	0.00155	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000796	0.00147	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000767	0.00142	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000549	0.00102	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000549	0.00102	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000549	0.00102	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00054	0.001	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000502	0.000931	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00049	0.000908	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000439	0.000813	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000418	0.000774	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000338	0.000627	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000338	0.000627	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000333	0.000617	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000333	0.000616	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00033	0.000612	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000309	0.000573	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000271	0.000501	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000477	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000205	0.00038	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000204	0.000377	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000143	0.000264	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	8.79e-05	0.000163	CbGpPWpGaD
